← Back to Search

Local Anesthetic

Erector Spinae Nerve Block for Thoracic Surgery

Phase 4
Waitlist Available
Led By Charles Luke, MD
Research Sponsored by Neal Shah, MD
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 0-120 hours post-operative
Awards & highlights

Study Summary

This trial will compare the efficacy, safety, and side-effect profile of continuous erector spinae plane analgesia (ESP) versus continuous paravertebral analgesia (PVB) for video-assisted thoracic surgery (VATS).

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~0-120 hours post-operative
This trial's timeline: 3 weeks for screening, Varies for treatment, and 0-120 hours post-operative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient Reported Pain Scores
Total Opioid Consumption
Secondary outcome measures
Amount Achieved on Incentive Spirometer
Averaged Total of Narcotic Usage
Length of Hospital Stay
+2 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Paravertebral Nerve BlockExperimental Treatment1 Intervention
Paravertebral nerve block
Group II: Erector Spinae Nerve BlockExperimental Treatment1 Intervention
Erector Spinae nerve block
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Paravertebral nerve block
2019
Completed Phase 4
~40
Erector Spinae nerve block
2019
Completed Phase 4
~40

Find a Location

Who is running the clinical trial?

Neal Shah, MDLead Sponsor
Charles LukeLead Sponsor
Nicholas Schott, MDStudy DirectorUniversity of Pittsburgh
~6 spots leftby Jun 2025